NTLA Snapshot | |
---|---|
Intellia Therapeutics, Inc., a genome editing company, is focused on developing therapies. The company is headquartered in Cambridge, Massachusetts. | |
VALUATION DATA | |
Market Capitalization | $2,653,498,000 | Price to Sales | 5.00 |
Earnings per Share | $-5.4200 |
PE Ratio | None |
PRICE DATA | |
Most Recent Close | $27.5100 |
52 Week High | $73.15 |
52 Week Low | $2.471 |
50-Day Moving Average | $49.57 |
200-Day Moving Average | $-3.551 |
All data are from Alpha Vantage as of today. For more infomation on NTLA see Stock Dividend, Valuation, Price and Financial Data for Investors |